Allegra Medical Technologies (ASX:AMT) Total Payout Ratio : 0.04 (As of May. 17, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Allegra Medical Technologies's current Total Payout Ratio is 0.04.

Allegra Medical Technologies Total Payout Ratio Historical Data

The historical data trend for Allegra Medical Technologies's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Total Payout Ratio Chart

Allegra Medical Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Payout Ratio

Get a 7-Day Free Trial

0.01

Allegra Medical Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	0.12

Competitive Comparison of Allegra Medical Technologies's Total Payout Ratio

For the Medical Devices subindustry, Allegra Medical Technologies's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allegra Medical Technologies's Total Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's Total Payout Ratio falls into.

Allegra Medical Technologies Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Allegra Medical Technologies's Total Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-3.648
	=	0.00

Allegra Medical Technologies's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-0.032	+	0.206	+	0)	/	-1.444
	=	0.12

Allegra Medical Technologies Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Allegra Medical Technologies (ASX:AMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066

Website

https://www.allegraorthopaedics.com

Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.